雀巢公司推出蛋白质注射来增加减肥药物的食欲抑制, 进入了价值1500亿美元的市场. Nestlé launches protein shots to boost appetite suppression for weight-loss drug users, entering the $150 billion market.

雀巢公司推出了“促进饮食前饥饿支持”计划,这是针对使用Wegovy和Zepbound等减重药物的人的蛋白质射击。 Nestlé has introduced Boost Pre-Meal Hunger Support, a protein shot aimed at people using weight-loss drugs like Wegovy and Zepbound. 每发一包四包,价格10.99美元,每发一发含有10克威氏蛋白质、45卡路里和1克糖,旨在通过引起自然激素反应来抑制食欲。 Priced at $10.99 for a pack of four, each shot contains 10 grams of whey protein, 45 calories, and 1 gram of sugar, designed to suppress appetite by triggering a natural hormone response. 该产品是雀巢公司进入日益增长的1 500亿美元的重量损失市场战略的一部分。 The product is part of Nestlé's strategy to enter the growing $150 billion weight-loss market.